Christine Rollier
Cited by
Cited by
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10269), 99-111, 2021
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ...
The Lancet 396 (10249), 467-478, 2020
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ...
The Lancet 396 (10267), 1979-1993, 2020
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10277), 881-891, 2021
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
JR Barrett, S Belij-Rammerstorfer, C Dold, KJ Ewer, PM Folegatti, ...
Nature medicine 27 (2), 279-288, 2021
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
M Ainsworth, M Andersson, K Auckland, JK Baillie, E Barnes, S Beer, ...
The Lancet Infectious Diseases 20 (12), 1390-1400, 2020
Viral vectors as vaccine platforms: deployment in sight
CS Rollier, A Reyes-Sandoval, MG Cottingham, K Ewer, AVS Hill
Current opinion in immunology 23 (3), 377-382, 2011
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
A Flaxman, NG Marchevsky, D Jenkin, J Aboagye, PK Aley, B Angus, ...
The Lancet 398 (10304), 981-990, 2021
Viral vectors as vaccine platforms: from immunogenicity to impact
KJ Ewer, T Lambe, CS Rollier, AJ Spencer, AVS Hill, L Dorrell
Current opinion in immunology 41, 47-54, 2016
Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass
R Alcock, MG Cottingham, CS Rollier, J Furze, SD De Costa, M Hanlon, ...
Science translational medicine 2 (19), 19ra12-19ra12, 2010
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
DJ Ahern, Z Ai, M Ainsworth, C Allan, A Allcock, B Angus, MA Ansari, ...
Cell 185 (5), 916-938. e58, 2022
Upregulation of indoleamine 2, 3-dioxygenase in hepatitis C virus infection
E Larrea, JI Riezu-Boj, L Gil-Guerrero, N Casares, R Aldabe, P Sarobe, ...
Journal of virology 81 (7), 3662-3666, 2007
CD8+ T effector memory cells protect against liver-stage malaria
A Reyes-Sandoval, DH Wyllie, K Bauza, A Milicic, EK Forbes, CS Rollier, ...
The Journal of Immunology 187 (3), 1347-1357, 2011
Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein
C Rollier, C Sunyach, L Barraud, N Madani, C Jamard, C Trepo, L Cova
Gastroenterology 116 (3), 658-665, 1999
Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response
C Rollier, E Depla, JAR Drexhage, EJ Verschoor, BE Verstrepen, A Fatmi, ...
Journal of virology 78 (1), 187-196, 2004
Natural mutations in a Staphylococcus aureus virulence regulator attenuate cytotoxicity but permit bacteremia and abscess formation
S Das, C Lindemann, BC Young, J Muller, B Österreich, N Ternette, ...
Proceedings of the National Academy of Sciences 113 (22), E3101-E3110, 2016
Vaccine‐induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD‐1 and chronicity
CS Rollier, G Paranhos‐Baccala, EJ Verschoor, BE Verstrepen, ...
Hepatology 45 (3), 602-613, 2007
Progress in DNA vaccine for prophylaxis and therapy of hepatitis B
A Thermet, C Rollier, F Zoulim, C Trepo, L Cova
Vaccine 21 (7-8), 659-662, 2003
Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime–boost immunisation in non-human primates
S Capone, A Reyes-Sandoval, M Naddeo, L Siani, V Ammendola, ...
Vaccine 29 (2), 256-265, 2010
MAIT cell activation augments adenovirus vector vaccine immunogenicity
NM Provine, A Amini, LC Garner, AJ Spencer, C Dold, C Hutchings, ...
Science 371 (6528), 521-526, 2021
The system can't perform the operation now. Try again later.
Articles 1–20